Data / Form D filings / Sound Pharmaceuticals Inc
Sound Pharmaceuticals Inc: Form D filings
Sound Pharmaceuticals Inc, a biotechnology company in Seattle, WA, filed 5 Form D notices with the SEC between 2012 and 2018. The latest, on June 6, 2018, reports $8.4 million sold of a $10.4 million offering to 5 investors.
Find out what Sound Pharmaceuticals Inc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 4010 STONE WAY NORTH, SUITE 120, Seattle, WA, 98103
- Phone
- (206) 634-2559
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1165353
The full lists. Form D filings in Washington: 1,095 rows, $54.75, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 6, 2018 | New notice | $10,408,576 | $8,408,576 | $2,000,000 | 5 | May 24, 2018 | sec.gov |
| Sep 16, 2016 | Amendment | $5,000,000 | $4,100,000 | $900,000 | 4 | Aug 7, 2015 | sec.gov |
| Aug 19, 2015 | New notice | $5,000,000 | $300,000 | $4,700,000 | 1 | Aug 7, 2015 | sec.gov |
| Oct 16, 2013 | Amendment | $10,000,002 | $7,563,366 | $2,436,636 | 21 | May 10, 2005 | sec.gov |
| Dec 17, 2012 | New notice | $2,000,000 | $1,515,105 | $484,895 | 9 | Dec 5, 2012 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| David Guyer | Director | |
| James C. Towne | Director | |
| Jonathan Kil | Executive Officer, Director | |
| Joseph Ashley | Director | |
| John C. Sullivan | Executive Officer | |
| Glenn Kawasaki | Director |
Other biotechnology companies in Washington that filed recently
- Key Proteo, Inc. $2.3 million · Oct 23, 2026
- Inmedix, Inc. $4 million · Oct 22, 2026
- Q-Immune, Inc. $25,000 · Sep 28, 2026
- Hexamer Therapeutics, Inc $500,000 · Sep 15, 2026
- MalarVx, Inc. $125,000 · Aug 25, 2026
- Strella Biotechnology, Inc. $1.8 million · Aug 14, 2026
Every Form D from the week of Jun 4, 2018 · All recent filings in Washington · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Sound Pharmaceuticals Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.